GLP-1R-话题@MedSci

#GLP-1R#

17篇内容 | 684人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1658673, encodeId=2e2716586e3f0, content=<a href='/topic/show?id=4b4d80e878' target=_blank style='color:#2F92EE;'>#GLP-1R#</a>, objectTitle=JAMA Intern Med：GLP-1RA与胆囊或胆道事件相关, objectType=article, longId=729050, objectId=44efe290500e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44efe290500e, replyNumber=0, likeNumber=48, createdTime=2022-11-07, rootId=0, userName=360611848, userId=fea024898996, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44efe290500e, moduleTitle=JAMA Intern Med：GLP-1RA与胆囊或胆道事件相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44efe290500e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658672, encodeId=4c8f16586e279, content=<a href='/topic/show?id=4b4d80e878' target=_blank style='color:#2F92EE;'>#GLP-1R#</a>, objectTitle=JAHA：SGLT2i和GLP-1RA对老年患者的心血管疗效比较, objectType=article, longId=295380, objectId=927829538021, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=927829538021, replyNumber=0, likeNumber=45, createdTime=2022-11-10, rootId=0, userName=360611848, userId=fea024898996, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=927829538021, moduleTitle=JAHA：SGLT2i和GLP-1RA对老年患者的心血管疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=927829538021)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658670, encodeId=5f5616586e09f, content=<a href='/topic/show?id=4b4d80e878' target=_blank style='color:#2F92EE;'>#GLP-1R#</a>, objectTitle=SoliMix结果公布：基础胰岛素与GLP-1RA的复方制剂与预混胰岛素的头对头比较研究, objectType=article, longId=213502, objectId=ee6b2135028f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee6b2135028f, replyNumber=0, likeNumber=37, createdTime=2021-12-28, rootId=0, userName=360611848, userId=fea024898996, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee6b2135028f, moduleTitle=SoliMix结果公布：基础胰岛素与GLP-1RA的复方制剂与预混胰岛素的头对头比较研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee6b2135028f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658671, encodeId=ca7016586e193, content=<a href='/topic/show?id=4b4d80e878' target=_blank style='color:#2F92EE;'>#GLP-1R#</a>, objectTitle=Diabetes Obes Metab：finerenone(非奈利酮)对GLP-1RA治疗慢性肾脏病和2型糖尿病患者的疗效和安全性, objectType=article, longId=219640, objectId=2997219640dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2997219640dc, replyNumber=0, likeNumber=40, createdTime=2022-06-01, rootId=0, userName=360611848, userId=fea024898996, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2997219640dc, moduleTitle=Diabetes Obes Metab：finerenone(非奈利酮)对GLP-1RA治疗慢性肾脏病和2型糖尿病患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2997219640dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658669, encodeId=b87c1658669f3, content=<a href='/topic/show?id=4b4d80e878' target=_blank style='color:#2F92EE;'>#GLP-1R#</a>, objectTitle=Lancet：从临床试验到临床实践，看真实世界中GLP-1RA的心血管获, objectType=article, longId=191128, objectId=316219112851, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=316219112851, replyNumber=0, likeNumber=36, createdTime=2020-11-28, rootId=0, userName=360611848, userId=fea024898996, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=316219112851, moduleTitle=Lancet：从临床试验到临床实践，看真实世界中GLP-1RA的心血管获, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=316219112851)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658668, encodeId=2333165866859, content=<a href='/topic/show?id=4b4d80e878' target=_blank style='color:#2F92EE;'>#GLP-1R#</a>, objectTitle=Lancet Diabetes Endo：荟萃分析显示GLP-1RA可减少心血管事件, objectType=article, longId=179437, objectId=26881e943795, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26881e943795, replyNumber=0, likeNumber=0, createdTime=2020-02-01, rootId=0, userName=360611848, userId=fea024898996, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26881e943795, moduleTitle=Lancet Diabetes Endo：荟萃分析显示GLP-1RA可减少心血管事件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26881e943795)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658665, encodeId=bce516586654d, content=<a href='/topic/show?id=4b4d80e878' target=_blank style='color:#2F92EE;'>#GLP-1R#</a>, objectTitle=Hypertension：2型糖尿病患者长期应用短效GLP-1RA对系统血流动力学的影响, objectType=article, longId=146095, objectId=6bd214609513, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6bd214609513, replyNumber=0, likeNumber=55, createdTime=2019-04-21, rootId=0, userName=360611848, userId=fea024898996, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6bd214609513, moduleTitle=Hypertension：2型糖尿病患者长期应用短效GLP-1RA对系统血流动力学的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6bd214609513)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658667, encodeId=8a1c165866ed0, content=<a href='/topic/show?id=4b4d80e878' target=_blank style='color:#2F92EE;'>#GLP-1R#</a>, objectTitle=Hepatology：丁酸钠可以通过上调肝脏GLP-1R表达减少高脂饮食诱导的非酒精性脂肪性肝炎, objectType=article, longId=158523, objectId=8bfb158523b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8bfb158523b9, replyNumber=0, likeNumber=35, createdTime=2019-04-06, rootId=0, userName=360611848, userId=fea024898996, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8bfb158523b9, moduleTitle=Hepatology：丁酸钠可以通过上调肝脏GLP-1R表达减少高脂饮食诱导的非酒精性脂肪性肝炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8bfb158523b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658666, encodeId=14e416586669a, content=<a href='/topic/show?id=4b4d80e878' target=_blank style='color:#2F92EE;'>#GLP-1R#</a>, objectTitle=Lancet：新型GIP/GLP-1R双靶点降糖新药II期数据惊艳，HbA1c下降达2.4%, objectType=article, longId=150492, objectId=25fa15049273, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25fa15049273, replyNumber=0, likeNumber=38, createdTime=2019-02-27, rootId=0, userName=360611848, userId=fea024898996, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25fa15049273, moduleTitle=Lancet：新型GIP/GLP-1R双靶点降糖新药II期数据惊艳，HbA1c下降达2.4%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25fa15049273)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658661, encodeId=e2a5165866164, content=<a href='/topic/show?id=4b4d80e878' target=_blank style='color:#2F92EE;'>#GLP-1R#</a>, objectTitle=Diabetes：利用靶向RNAi筛查探寻调控胰腺β细胞GLP-1R的内吞转运因子——治疗T2D的新的药物靶点。, objectType=article, longId=125269, objectId=94b412526921, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94b412526921, replyNumber=0, likeNumber=28, createdTime=2018-07-30, rootId=0, userName=360611848, userId=fea024898996, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94b412526921, moduleTitle=Diabetes：利用靶向RNAi筛查探寻调控胰腺β细胞GLP-1R的内吞转运因子——治疗T2D的新的药物靶点。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=94b412526921)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658662, encodeId=7ca916586629a, content=<a href='/topic/show?id=4b4d80e878' target=_blank style='color:#2F92EE;'>#GLP-1R#</a>, objectTitle=J Clin Lipidol：血脂异常的T2DM患者：GLP-1RAs+他汀是个不错的选择？, objectType=article, longId=129344, objectId=1d9d12934457, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d9d12934457, replyNumber=0, likeNumber=50, createdTime=2018-07-11, rootId=0, userName=360611848, userId=fea024898996, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d9d12934457, moduleTitle=J Clin Lipidol：血脂异常的T2DM患者：GLP-1RAs+他汀是个不错的选择？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d9d12934457)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658663, encodeId=9bf316586636d, content=<a href='/topic/show?id=4b4d80e878' target=_blank style='color:#2F92EE;'>#GLP-1R#</a>, objectTitle=Diabetes Obes Metab：T2DM患者联合服用Canagliflozin与GLP-1RA的疗效和安全性分析！, objectType=article, longId=131067, objectId=333a13106e16, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=333a13106e16, replyNumber=0, likeNumber=32, createdTime=2018-12-29, rootId=0, userName=360611848, userId=fea024898996, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=333a13106e16, moduleTitle=Diabetes Obes Metab：T2DM患者联合服用Canagliflozin与GLP-1RA的疗效和安全性分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=333a13106e16)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658664, encodeId=54f9165866403, content=<a href='/topic/show?id=4b4d80e878' target=_blank style='color:#2F92EE;'>#GLP-1R#</a>, objectTitle=Am Heart J：胰岛素治疗的2型糖尿病患者添加GLP-1RA喜忧参半, objectType=article, longId=131184, objectId=80e513118486, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80e513118486, replyNumber=0, likeNumber=40, createdTime=2018-08-24, rootId=0, userName=360611848, userId=fea024898996, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80e513118486, moduleTitle=Am Heart J：胰岛素治疗的2型糖尿病患者添加GLP-1RA喜忧参半, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80e513118486)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658660, encodeId=e80b165866077, content=<a href='/topic/show?id=4b4d80e878' target=_blank style='color:#2F92EE;'>#GLP-1R#</a>, objectTitle=Diabetes Obes Metab：治疗2型糖尿病众多GLP-1RA排座次, objectType=article, longId=95493, objectId=77e9954938e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77e9954938e, replyNumber=0, likeNumber=34, createdTime=2017-09-12, rootId=0, userName=360611848, userId=fea024898996, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77e9954938e, moduleTitle=Diabetes Obes Metab：治疗2型糖尿病众多GLP-1RA排座次, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77e9954938e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658659, encodeId=a66916586599e, content=<a href='/topic/show?id=4b4d80e878' target=_blank style='color:#2F92EE;'>#GLP-1R#</a>, objectTitle=EASD 2016：阿斯利康2型糖尿病组合疗法Bydureon/Forxiga（GLP-1RA/SGLT-2i）III期临床显著降低血糖水平、体重、收缩压, objectType=article, longId=78308, objectId=7164e8308d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7164e8308d1, replyNumber=0, likeNumber=29, createdTime=2017-01-08, rootId=0, userName=360611848, userId=fea024898996, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7164e8308d1, moduleTitle=EASD 2016：阿斯利康2型糖尿病组合疗法Bydureon/Forxiga（GLP-1RA/SGLT-2i）III期临床显著降低血糖水平、体重、收缩压, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7164e8308d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658657, encodeId=894d165865eec, content=<a href='/topic/show?id=4b4d80e878' target=_blank style='color:#2F92EE;'>#GLP-1R#</a>, objectTitle=NEJM新闻：快讯！每周一次GLP-1RAs，治疗2型糖尿病, objectType=article, longId=60426, objectId=1e26604262f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e26604262f, replyNumber=0, likeNumber=41, createdTime=2016-06-05, rootId=0, userName=360611848, userId=fea024898996, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e26604262f, moduleTitle=NEJM新闻：快讯！每周一次GLP-1RAs，治疗2型糖尿病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e26604262f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1658658, encodeId=dca8165865870, content=<a href='/topic/show?id=4b4d80e878' target=_blank style='color:#2F92EE;'>#GLP-1R#</a>, objectTitle=AIM：GLP-1RAs治疗2型糖尿病—受益和损害, objectType=article, longId=60432, objectId=0aae6043274, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0aae6043274, replyNumber=0, likeNumber=34, createdTime=2016-03-08, rootId=0, userName=360611848, userId=fea024898996, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0aae6043274, moduleTitle=AIM：GLP-1RAs治疗2型糖尿病—受益和损害, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0aae6043274)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

GLP-1R

2020-05-29

360611848 (审核中...)

前往app查看评论内容

#GLP-1R#

JAMA Intern Med：GLP-1RA与胆囊或胆道事件相关

2022-11-07

360611848 (审核中...)

前往app查看评论内容

#GLP-1R#

JAHA：SGLT2i和GLP-1RA对老年患者的心血管疗效比较

2022-11-10

360611848 (审核中...)

前往app查看评论内容

#GLP-1R#

SoliMix结果公布：基础胰岛素与GLP-1RA的复方制剂与预混胰岛素的头对头比较研究

2021-12-28

360611848 (审核中...)

前往app查看评论内容

#GLP-1R#

Diabetes Obes Metab：finerenone(非奈利酮)对GLP-1RA治疗慢性肾脏病和2型糖尿病患者的疗效和安全性

2022-06-01

360611848 (审核中...)

前往app查看评论内容

#GLP-1R#

Lancet：从临床试验到临床实践，看真实世界中GLP-1RA的心血管获

2020-11-28

360611848 (审核中...)

前往app查看评论内容

#GLP-1R#

Lancet Diabetes Endo：荟萃分析显示GLP-1RA可减少心血管事件

2020-02-01

360611848 (审核中...)

前往app查看评论内容

#GLP-1R#

Hypertension：2型糖尿病患者长期应用短效GLP-1RA对系统血流动力学的影响

2019-04-21

360611848 (审核中...)

前往app查看评论内容

#GLP-1R#

Hepatology：丁酸钠可以通过上调肝脏GLP-1R表达减少高脂饮食诱导的非酒精性脂肪性肝炎

2019-04-06

360611848 (审核中...)

前往app查看评论内容

#GLP-1R#

Lancet：新型GIP/GLP-1R双靶点降糖新药II期数据惊艳，HbA1c下降达2.4%

2019-02-27

360611848 (审核中...)

前往app查看评论内容

#GLP-1R#

Diabetes：利用靶向RNAi筛查探寻调控胰腺β细胞GLP-1R的内吞转运因子——治疗T2D的新的药物靶点。

2018-07-30

360611848 (审核中...)

前往app查看评论内容

#GLP-1R#

J Clin Lipidol：血脂异常的T2DM患者：GLP-1RAs+他汀是个不错的选择？

2018-07-11

360611848 (审核中...)

前往app查看评论内容

#GLP-1R#

Diabetes Obes Metab：T2DM患者联合服用Canagliflozin与GLP-1RA的疗效和安全性分析！

2018-12-29

360611848 (审核中...)

前往app查看评论内容

#GLP-1R#

Am Heart J：胰岛素治疗的2型糖尿病患者添加GLP-1RA喜忧参半

2018-08-24

360611848 (审核中...)

前往app查看评论内容

#GLP-1R#

Diabetes Obes Metab：治疗2型糖尿病众多GLP-1RA排座次

2017-09-12

360611848 (审核中...)

前往app查看评论内容

#GLP-1R#

EASD 2016：阿斯利康2型糖尿病组合疗法Bydureon/Forxiga（GLP-1RA/SGLT-2i）III期临床显著降低血糖水平、体重、收缩压

2017-01-08

360611848 (审核中...)

前往app查看评论内容

#GLP-1R#

NEJM新闻：快讯！每周一次GLP-1RAs，治疗2型糖尿病

2016-06-05

360611848 (审核中...)

前往app查看评论内容

#GLP-1R#

AIM：GLP-1RAs治疗2型糖尿病—受益和损害

2016-03-08

科室
- - 订阅+
  - 更多科室
工具
服务